Vivera announced today that it received a third U.S. patent for its Zicoh electronic dose-controlled drug delivery device portfolio. Newport Beach, California–based Vivera’s latest patent from the U.S. Patent and Trademark Office (USPTO) secures Zicoh’s rights as a smart dosing system with automated delivery, measurement, and management for oral format medications, including pills, capsules and […]
Glucose monitor maker Know Labs expands leadership team
Non-invasive glucose monitor developer Know Labs (OTCQB:KNWN) announced today that it added two executives to its leadership team. Seattle-based Know Labs — which aims to make the first non-invasive glucose monitor cleared by the FDA — added Steven Kent as its new chief product officer, along with Peter Conley as its CFO and SVP of […]
Report: Dexcom in talks to acquire Insulet
Major players in the diabetes space could join forces as Dexcom (Nasdaq:DXCM) is reportedly in discussions to acquire Insulet (Nasdaq:PODD). Bloomberg reported today that people “with knowledge of the matter” have said talks are ongoing over a potential acquisition and even said an agreement could be reached “in the coming weeks.” Bloomberg said its sources preferred […]
How Glytec is advancing insulin management in the hospital
Growth and new partnerships have Glytec excited for the future of its Glucommander insulin dosing decision support software. After years of running a hospitalist group and mentoring hospitals on quality improvement, blood clot prevention and more, Dr. Jordan Messler found himself falling into a lot of work on diabetes. Messler cut his teeth on quality […]
Alcon to pay $60M to acquire Kala Pharmaceuticals’ dry eye treatment
Alcon (NYSE:ACL) announced today that it agreed to acquire Eysuvis pharmaceutical eye drops from Kala Pharmaceuticals. Geneva, Switzerland-based Alcon will pay $60 million upfront to Kala for the dry eye treatment. As part of the agreement, the company will also acquire Kala’s Inveltys corticosteroid for twice-per-day treatment of post-operative inflammation and pain following ocular surgery. […]
BD, Mitsubishi Gas Chemical partner on better materials for plastic syringes
BD (NYSE:BDX) announced that it partnered with Mitsubishi Gas Chemical Company on applying new technology to pre-fillable syringes. MGC develops the Oxycapt technology designed to integrate the best of plastic and glass for plastic syringes. BD and Tokyo-based MGC will work together to apply Oxycapt technology to the next generation of pre-fillable syringes (PFS) for […]
ApiJect picks up $111M investment from Royalty Pharma, Jefferies
Injection delivery system developer ApiJect announced today that it completed a private investment round worth $111 million. Royalty Pharma and Jefferies Financial Group led the investment round. Jefferies also acquired a revenue interest in addition to equity through the financing. According to a news release, the investment round values ApiJect at approximately $300 million. Jefferies […]
FDA approves IND for Ananda Scientific’s PTSD treatment with liquid structure delivery tech
Ananda Scientific announced that it received an FDA investigational new drug (IND) approval for a post-traumatic stress disorder (PTSD) treatment. The company will collaborate with the University of Nebraska Medical Center to conduct a clinical trial, led by Dr. Mathew Rizzo, Reynolds Professor and Chair of the UNMC Department of Neurological Sciences and Chief Physician […]
Medtronic’s Resolute Onyx drug-eluting stent demonstrates strong safety, efficacy
Data presented today at the EuroPCR 2022 event supported the use of the Medtronic (NYSE:MDT) Resolute Onyx drug-eluting stent. University of Padua Medical School Head of Interventional Cardiology Dr. Giuseppe Tarantini presented late-breaking clinical trial results from the investigator-initiated, Medtronic-funded ROLEX (Revascularization Of LEft Main With Resolute onyX) registry. ROLEX, the largest real-world, multicenter prospective […]
Jabil launches Qfinity reusable auto-injector
Jabil’s (NYSE:JBL) Jabil Healthcare division announced today that it launched its Qfinity auto-injector platform. St. Petersburg, Florida-based Jabil Healthcare designed the reusable Qfinity platform for simple subcutaneous drug self-administration at a lower cost than market alternatives. According to a news release, the Qfinity platform supports “the emerging prioritization” of sustainable drug delivery within the pharmaceutical […]